| Data | Hora | Fonte | Título | Código | Companhia |
| 06/12/2018 | 20:10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 06/12/2018 | 19:18 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 04/12/2018 | 20:53 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 09/11/2018 | 19:19 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 26/10/2018 | 17:59 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 17/08/2018 | 08:01 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 14/08/2018 | 18:06 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 07/08/2018 | 18:04 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 16/05/2018 | 17:09 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 17/04/2018 | 10:00 | GlobeNewswire Inc. | Oncobiologics Appoints Randy Thurman to Board of Directors | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 02/04/2018 | 07:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 27/03/2018 | 17:23 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 27/03/2018 | 10:00 | GlobeNewswire Inc. | Oncobiologics Appoints Dr. Joerg Windisch to Board of Directors | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 15/02/2018 | 20:32 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 15/02/2018 | 20:31 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 14/02/2018 | 12:00 | GlobeNewswire Inc. | Oncobiologics Reports First Quarter Fiscal Year 2018 Results | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 13/02/2018 | 19:36 | GlobeNewswire Inc. | Oncobiologics Receives Positive Nasdaq Listing Determination | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 09/02/2018 | 12:00 | GlobeNewswire Inc. | Oncobiologics Announces Term Extension of Series A Warrants | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 29/01/2018 | 21:05 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 29/12/2017 | 19:20 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 31/10/2017 | 11:00 | GlobeNewswire Inc. | Oncobiologics Announces Closing of Strategic Partnership Deal with GMS Tenshi Holdings | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 29/09/2017 | 17:12 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 27/09/2017 | 17:51 | Edgar (US Regulatory) | Proxy Soliciting Materials (revised) (prer14a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 25/09/2017 | 17:48 | Edgar (US Regulatory) | Small Company Offering and Sale of Securities Without Registration (d) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 25/09/2017 | 17:01 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (3/a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 18/09/2017 | 18:17 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 08/09/2017 | 09:31 | GlobeNewswire Inc. | Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 15/08/2017 | 09:22 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 01/06/2017 | 10:00 | GlobeNewswire Inc. | Oncobiologics Closes on Final Portion of $15 Million Senior Secured Note and Warrant Offering | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 09/05/2017 | 10:00 | GlobeNewswire Inc. | Oncobiologics to Present at the World Biosimilar Congress 2017 | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |